Evicenter
Rexulti (brexpiprazole) in Major depressive disorder
Manufacturer
Otsuka America Pharmaceutical, Inc.; Lundbeck
Prescribing information
Rexulti (opens in a new tab)
Questions
35
Last updated

All questions

Clinical trials: Rexulti (brexpiprazole) in major depressive disorder

8 questions · 4 sources

Clinical trials

How were the Rexulti adjunctive depression trials designed?

Rexulti and adjunctive atypical antipsychotics: what did a class meta-analysis find?

Note: The partial response page of the Rexulti HCP site cites this meta-analysis as Wen et al., Braz J Med Biol Res, 2014, which pooled trials of adjunctive atypical antipsychotics as a class. The brexpiprazole phase 3 trials that the site cites elsewhere were published in 2015.

Outcome measures

What is the MADRS score used in Rexulti depression trials?

Study results

How effective is Rexulti added to an antidepressant (Studies 1 and 2)?

Note: Table 13 lists, for each study and treatment group, N, mean baseline score (SD), LS mean change from baseline (SE), and the placebo-subtracted difference (95% CI).

Is Rexulti 1 mg effective for depression?

When did Rexulti first separate from placebo in depression trials?

Note: The weekly results are from Study 1, as shown on the non-pivotal study data page of the Rexulti HCP site.

Subgroup results

Does Rexulti work in depression with anxiety symptoms (post hoc analysis)?

Does Rexulti response differ by age, sex, or race?